Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

Stocks turned lower in afternoon trading, and that pressure continued through Friday. The S&P 500 fell as much as 1.6%, and ...

The odds of a 25-basis-point rate cut fell to less than 60% shortly after Powell's comments, down from 80%, as calculated by ...

Indexes slipped as traders zeroed in on remarks from Fed Chair Jerome Powell, who said the central bank is in no hurry to cut ...

Since its launch, Mint Mobile has gained popularity for its innovative approach, providing consumers with affordable, ...

Trump's transition team is looking to do away with the $7,500 tax credit for EV sales as part of broader tax legislation, ...

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid ...

Barclays analyst George Wang CFA has maintained their neutral stance on SMCI stock, giving a Hold rating on November 5. George Wang ...

Analyst Andrew Percoco from Morgan Stanley maintained a Buy rating on Bloom Energy (BE – Research Report) and keeping the price target at ...

Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), with a price ...

Akamai (AKAM) announced it is the winning bidder to acquire select assets from Edgio, including customer contracts from Edgio’s ...

Whitbread (WTB – Research Report) received a Hold rating and a price target from Barclays analyst Vicki Stern today. The company’s ...